Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.2 INR | +0.88% | -0.39% | +3.17% |
09:18am | Marksans Pharma Gets Marketing Approval for Levetiracetam Relonchem in UK | MT |
18/04 | Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.17% | 90Cr | |
+37.94% | 73TCr | |
-7.89% | 35TCr | |
+15.48% | 33TCr | |
-0.39% | 28TCr | |
+13.47% | 24TCr | |
+7.35% | 21TCr | |
-6.42% | 20TCr | |
+4.11% | 16TCr | |
-1.82% | 16TCr |
- Stock Market
- Equities
- MARKSANS Stock
- News Marksans Pharma Limited
- Transcript : Marksans Pharma Limited, Q4 2022 Earnings Call, Jun 01, 2022